Recommendation

Recommended In Favor

Conditional recommendation

Management of visceral leishmaniasis (VL) patients in eastern Africa. Use of liposomal amphotericin B (LAmB) is suggested in patients in whom paromomycin plus miltefosine and/or pentavalent antimonial plus paromomycin is excluded
Year
2026
Institution
World health organization
Guideline
Not available